Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENWT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,070
Award facts
- Contract value 100% obligated
- $17,070.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,070.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on October 28, 2025, with an ultimate completion date of October 29, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to Department of Defense healthcare facilities, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying PPV-G GEN V contract, designated SPE2DR and awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 with an ultimate completion date of December 31, 2036, and includes a 30-month base period with three 30-month option periods. Through this vehicle, DMS Pharmaceutical Group serves as a critical regional pharmaceutical supplier supporting military healthcare operations globally, leveraging its established federal contracting experience and extensive product portfolio to fulfill the specialized pharmaceutical requirements of the Department of Defense medical system.
Quick answers
Who was awarded contract SPE2DU26FENWT?
SPE2DU26FENWT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DU26FENWT worth?
The government has obligated $17,070 on SPE2DU26FENWT.
Is contract SPE2DU26FENWT an order under another contract?
Yes. SPE2DU26FENWT is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENWT competed?
The extent of competition for SPE2DU26FENWT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award